Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8725220 | Clinical Gastroenterology and Hepatology | 2018 | 46 Pages |
Abstract
In an analysis of data collected from UK and US national liver transplant registries over 20 years, we found that PSC has become the leading indication for liver transplantation among patients with autoimmune liver diseases. Numbers of patients with PBC placed on waitlists, and the ratio of women:men with PBC, each decreased by almost 50%, possibly due to increased treatment with ursodeoxycholic acid. Within groups of patients on the transplant waitlist for PBC, PSC, or AIH, we found differences in age, sex, disease severity scores, and ethnicity between diseases and countries that require further study.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Gwilym James Webb, Abbas Rana, James Hodson, Mohammed Zeeshan Akhtar, James Walter Ferguson, James Max Neuberger, John Moore Vierling, Gideon Morris Hirschfield,